Open access · US-GOV
via ClinicalTrials.gov Clinical trial
Cholinergic Deep Brain Stimulation for Alzheimer's Disease
Authors not listed
Vanderbilt University Medical Center · 2026
Abstract
This project will investigate the potential of Deep Brain Stimulation to improve cognitive abilities and counteract the effects of Alzheimer's disease. Deep Brain Stimulation electrodes targeting the Nucleus Basalis of Meynert (NB) will be implanted bilaterally in a cohort of patients. NB is the sole source of acetylcholine to the neocortex. Such stimulation may not only treat the cognitive symptoms but may have disease-modifying effects. Drawing from animal experiments in non-human primates that showed success of this approach, intermittent stimulation will be delivered at 60 pulses per second for 20 seconds of each minute for one hour per day. The study team will recruit patients, shortly after first being diagnosed with Alzheimer's disease. The study design will test the safety and efficacy of stimulation, potential benefits in cognitive function assessed with a battery of neurocognitive tests, cholinergic neurotransmission evaluated with Positron Emission Tomography, and ability to reverse Alzheimer's biomarkers, including beta amyloid and tau in the cerebrospinal fluid. Successful completion of this project will lead to a potential new intervention for the cognitive impairments of Alzheimer's disease.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-11-13 MST
Cite this
APA
Anonymous. (2026). Cholinergic Deep Brain Stimulation for Alzheimer's Disease. <em>Vanderbilt University Medical Center</em>. https://clinicaltrials.gov/study/NCT05882344
Vancouver
Anonymous. Cholinergic Deep Brain Stimulation for Alzheimer's Disease. Vanderbilt University Medical Center. 2026.
BibTeX
@misc{anon2026Cholin,
title = {Cholinergic Deep Brain Stimulation for Alzheimer's Disease},
author = {Anonymous},
journal = {Vanderbilt University Medical Center},
year = {2026},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
University of Cologne 2010
Open access · US-GOV
Deep Brain Stimulation of the Nucleus Basalis Meynert to Treat Cognitive Deficits in Light to Moderate Alzheimer's Disease
Ali Rezai, MD 2012
Open access · US-GOV
Deep Brain Stimulation (DBS) for Treatment of the Cognitive, Behavioral, and Functional Disability of Alzheimer's Disease
University of Pittsburgh 2019
Open access · US-GOV
Influence of Strategy Training on Disability for Older Adults With Mild Cognitive Impairment
Hoffmann-La Roche 2009
Open access · US-GOV
A Dose-ranging, Randomized, Double-blind , Placebo-controlled Study of the Effect of RO5313534, Used as add-on Therapy to Donepezil, on Cognitive Function in Patients With Mild to Moderate Symptoms of Alzheimer's Disease
Merck Sharp & Dohme LLC 2006
Open access · US-GOV
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Trial to Evaluate the Safety and Efficacy of MK0249 for the Symptomatic Treatment of Alzheimer's Disease
Samsung Medical Center 2014
Open access · US-GOV